Bharat Biotech completes recruitment of 13,000 volunteers for Phase III trials of Covaxin

Bharat Biotech has signed up 13,000 volunteers for the Phase 3 trial,
backed by India's government medical research body, and is progressing
towards its goal of 26,000, the company said. The trial began in
mid-November at multiple sites across India.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indian-covid-19-vaccine-maker-says-recruitment-for-trials-on-track/articleshow/79853518.cms

Comments

Popular posts from this blog

Pharma Production Executive Post Vacancy @ Intas

Pharos of Chaos

HILR Intersession: Mollie Crawford-Volk: Velazquez' "Las Meninas" and its Modern Progeny